Search
for
Sort by
Research 31–60 of 695
- Postherpetic Poliosis
- Letters: CD4+ Lymphocytopenia in Systemic Lupus Erythematosus
- Alopecia as a systemic disease
- Alopecias Due to Drugs and Other Skin and Systemic Disorders
- Isomorphic and isotopic phenomenon occurring simultaneously in a case of granuloma annulare
- Cutaneous Adverse Drug Reactions (CADRs) to COVID19 vaccines: A case series
- Diagnosis of stress-associated dermatologic conditions in New York City safety-net hospitals during the COVID-19 pandemic
- Social isolation: main dermatosis and the impact of stress during the COVID-19 pandemic
- Effects of Wet Cupping on Blood Components Specially Skin-Related Parameters of Healthy Cases: A Case Control Metabonomic Study
- [Mycophenolate mofetil in induction and maintenance therapy for juvenile onset severe lupus nephritis].
- Updated Integrated Safety Analysis of Ritlecitinib Up to ~5 Years in Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program
- Cutaneous manifestations associated with COVID-19 infection at a university hospital in eastern China
- Post Herpetic Itch Leading to Frictional Alopecia of Eyebrow and Scalp-A Hitherto Undescribed Phenomenon
- Viruses, Variants, and Vaccines: How COVID-19 Has Changed the Way We Look at Skin
- Cutaneous Manifestations of COVID-19
- Hair and Scalp Infections
- Janus Kinase (JAK) Inhibitors in Dermatology: An Update and Critical Review
- Updated Integrated Safety Analysis of Ritlecitinib Over 72 Months In Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program
- Shared Spaces: Decoding Dual Dermatoses in a Single Dermatome
- Rates of Infections, Malignancies, Cardiovascular Outcomes, and Death in Individuals with Hospital-treated Alopecia Areata: A Registry-based Cohort Study in Denmark
- Current best evidence in pigmentary dermatology
- A clinical study of Geriatric dermatoses at Tertiary care center in South India
- Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program
- Baricitinib: Exploring the Safety Profile for the Treatment of Alopecia Areata
- Dermatological manifestations associated with COVID‐19 and COVID‐19 vaccination: results from the Lebanese COVID registry
- Dermatological Issues Among Individuals Receiving Palliative Care - A Review
- Three years on, COVID-19 and the skin: long-term impacts, emerging trends and clinical practice
- The Effect of the COVID-19 Pandemic on Stress-related Dermatologic Diseases.
- Comparison of the Diagnoses of Dermatology Patients in COVID-19 Period with Previous Year: What Has Changed?
- Change in dermatology practice during crisis and normalization periods after the COVID-19 pandemic and potential problems awaiting us